Position in CELC
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$488,680
+$12,603 QoQ
Shares Held
4,671
+12.0% QoQ
Ownership
0.010%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#172
of 273 holders
Holding Since
Dec 2025
3 quarters on record
Common Shares in CELC Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Simplicity Wealth,LLC holds $3,408,474 across 10 Biotechnology names. CELC ranks #3 (14.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,792 | $1,386,870 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,173 | $731,412 | |
| 3 | CELC |
Celcuity Inc.
This page
|
4,671 | $488,680 | |
| 4 | REPL |
Replimune Group, Inc.
|
31,101 | $344,288 | |
| 5 | MRNA |
Moderna, Inc.
|
3,419 | $239,432 | |
| 6 | CMPX |
Compass Therapeutics, Inc.
|
36,480 | $79,891 | |
| 7 | CCCC |
C4 Therapeutics, Inc.
|
10,045 | $46,910 | |
| 8 | CDXS |
Codexis, Inc.
|
17,438 | $39,409 |
All Filings in CELC
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $488,680 | 4,671 | Shares | Sole | 2026-08-06 | |
| 2026-03-31 | $476,077 | 4,171 | Shares | Sole | 2026-04-30 | |
| 2025-12-31 | $580,287 | 5,818 | Shares | Sole | 2026-01-30 | |
| No filing history on record for this holder in this stock. | ||||||